Georgia Launches Third Year of Opioid Settlement Grants With $20 Million for Treatment and Recovery

Georgia opened applications this week for the third year of its Opioid Crisis Abatement Trust grant program, making $20 million available to organizations working to reduce addiction and overdose deaths across the state. The funding round represents the latest phase of Georgia's systematic deployment of settlement dollars from pharmaceutical manufacturers and distributors, with the state now having allocated more than $90 million since the program began in 2023.

The Georgia Opioid Crisis Abatement Trust manages 75% of the state's share from national settlements with Janssen, McKesson Corporation, Cencora, and Cardinal Health—companies that played central roles in fueling the prescription opioid epidemic. Georgia is set to receive approximately $1.3 billion over 18 years, with $479 million currently available through the trust for prevention, treatment, and recovery initiatives.

Regional Approach Targets Highest-Need Areas

This year's $20 million allocation follows a split structure: $14 million will be distributed through regional advisory councils and local governments, while $6 million will be overseen directly by the trust's trustee. The regional approach allows funding to flow toward areas with the greatest demonstrated need, with North Georgia slated to receive the largest share due to persistently high overdose death rates.

Kevin Tanner, who serves as both Georgia's Commissioner of Behavioral Health and Developmental Disabilities and trustee of the abatement fund, emphasized that successful applications will identify specific service gaps rather than proposing generic programming. At an information session in Forsyth County for North Georgia applicants, Tanner outlined the trust's evolving strategy: identifying remaining gaps and creating targeted funding opportunities to fill them.

The trust is collaborating with the University of Georgia's David Ralston Institute for Behavioral Health and Developmental Disabilities to build a comprehensive data clearinghouse. This resource overlays overdose rates, opioid prescription patterns, and behavioral health workforce distribution to guide funding decisions—moving beyond the gap analysis published in 2024 toward real-time, geographically precise resource allocation.

Treatment Remains Top Priority

In 2025, the trust directed approximately $18 million—its largest single category—toward projects focused on treating opioid use disorder. These initiatives span hospitals, outpatient medication-assisted treatment centers, and local government agencies, reflecting the trust's emphasis on expanding clinical capacity where evidence shows it saves lives.

Medication-assisted treatment using buprenorphine, methadone, and naltrexone has demonstrated the capacity to reduce overdose mortality by more than 50% compared to no treatment, yet access remains uneven across Georgia's 159 counties. Rural areas particularly struggle with provider shortages and transportation barriers that make daily or weekly clinic visits impractical for many patients.

Recovery services received the second-largest allocation in previous funding rounds, supporting the infrastructure needed to help individuals maintain stability after completing initial treatment. Recovery residences—sober living environments that provide structure, peer support, and accountability—represent one component of this continuum, though organizations in this sector report that navigating the application process can prove challenging for smaller, grassroots operations.

Kristin Carlin, who works at a recovery residence for women in Athens, described her organization's second year applying for trust funds. Recovery residences function as one prong of a multi-faceted approach, providing stable housing and community connections for women rebuilding their lives after addiction. Carlin noted that these facilities help residents "get back on their feet and get back out in the world to be a mom, a daughter, a sister—everything they were meant to be."

Applications Open Through May

Organizations seeking funding can submit applications through the Georgia Opioid Crisis Abatement Trust website throughout the month of May. The trust plans to announce grant recipients in fall 2026, with programs expected to launch by January 2027.

The application process requires detailed proposals outlining how projects will address specific community needs, measurable outcomes, and sustainable implementation plans. While the trust maintains flexibility for "innovative ideas," Tanner indicated that proposals demonstrating clear alignment with identified gaps—backed by local data—will receive strongest consideration.

Georgia's structured approach to settlement fund deployment stands in contrast to states where opioid dollars have been diverted to general budgets or spent without clear strategic frameworks. The 75/25 split between state-managed trust funds and direct local government allocations ensures both coordinated statewide planning and community-level autonomy in addressing local conditions.

Context of National Progress

The Georgia funding round arrives during a period of measured optimism in national overdose trends. Provisional CDC data shows U.S. drug overdose deaths declining approximately 19% since peaking in August 2023—the longest sustained decrease in over four decades. Multiple factors likely contribute: expanded naloxone availability, increased medication-assisted treatment access through telehealth and regulatory reforms, and shifts in illicit fentanyl supply dynamics.

However, public health experts caution that sustaining these improvements requires continued investment in the treatment infrastructure that settlement funds help build. Georgia's multi-year funding commitment—spanning the full 18-year settlement payment schedule—offers rare predictability in a field typically subject to annual appropriations cycles and political volatility.

Whether the trust's strategic, data-informed approach translates into measurable mortality reductions across Georgia's diverse regions remains to be documented. What is clear is that the $20 million now available represents more than financial resources—it embodies a sustained commitment to addressing a crisis that has claimed thousands of Georgia lives and continues to evolve as new synthetic substances enter illicit drug markets.

For organizations on the front lines of addiction treatment and recovery, the application window opening this month offers an opportunity to secure funding that could expand services to individuals and communities currently beyond reach of existing programs. The trust's challenge lies in selecting proposals that demonstrate both immediate impact potential and sustainable integration into Georgia's broader behavioral health infrastructure.